In fact, in 2021 we’ve seen more digital therapeutics emerge onto the market, while pharma companies and startups work together on collecting real-world data, and investments continue in decentralized clinical trials.
In early 2021, Otsuka Pharmaceuticals and digital therapeutics company Click Therapeutics announced a new remote clinical trial being conducted on Verily’s Project Baseline platform.
Over the summer, Happify Health announced the launch of its first prescription digital therapeutic , named Ensemble, which is focused on Major Depressive Disorder and Generalized Anxiety Disorder.
In addition to going public, Pear also embarked on a slew of deals.
AstraZeneca is also looking at the real-world data space.
The decentralized clinical trial space is also heating up.
TrialSpark, a health-tech platform that lets providers become clinical trial sites, scored a whopping $156 million over the fall.